Neil F. McFarlane, President and CEO of ZeVRA Therapeutics, Inc. ($ZVRA), sold about $1.19 million worth of company shares in three open market transactions over the past year. His most recent sale occurred on February 9, 2026. These sales rank 4,535th among 11,678 individual insiders, below the average of $8.6 million per seller across about 6.4 transactions. McFarlane made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 7, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 37500 | $0.00 | 75,000.0000 | 56,783,000 | 33.33% | 0.07% |
| Feb. 7, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Common Stock | 37500 | $0.00 | 401,850.0000 | 56,783,000 | 10.29% | 0.07% |
| Feb. 9, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | S | Common Stock | 14625 | $8.56 | 387,225.0000 | 56,783,000 | 3.64% | 0.03% |
| Jan. 29, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 56,783,000 | 9999.99% | 0.44% |
| Jan. 31, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 233334 | $0.00 | 233,333.0000 | 56,783,000 | 50.00% | 0.41% |
| Jan. 31, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Common Stock | 233334 | $0.00 | 455,350.0000 | 56,783,000 | 105.10% | 0.41% |
| Feb. 2, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | S | Common Stock | 91000 | $9.38 | 364,350.0000 | 56,783,000 | 19.98% | 0.16% |
| Jan. 29, 2026 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 125000 | $0.00 | 125,000.0000 | 56,783,000 | 9999.99% | 0.22% |
| Oct. 10, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | S | Common Stock | 19500 | $10.82 | 222,016.0000 | 56,783,000 | 8.07% | 0.03% |
| Oct. 10, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Common Stock | 50000 | $0.00 | 241,516.0000 | 56,783,000 | 26.11% | 0.09% |
| Oct. 10, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 50000 | $0.00 | 100,000.0000 | 56,783,000 | 33.33% | 0.09% |
| Feb. 13, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | S | Common Stock | 61273 | $7.86 | 222,060.0000 | 47,808,817 | 21.63% | 0.13% |
| Feb. 14, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | S | Common Stock | 30544 | $8.05 | 191,516.0000 | 47,808,817 | 13.75% | 0.06% |
| Feb. 7, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 112500 | $0.00 | 112,500.0000 | 47,808,817 | 9999.99% | 0.24% |
| Feb. 7, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | A | Stock Option (right to buy) | 225000 | $0.00 | 225,000.0000 | 47,808,817 | 9999.99% | 0.47% |
| Jan. 31, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Common Stock | 233333 | $0.00 | 283,333.0000 | 47,808,817 | 466.67% | 0.49% |
| Jan. 31, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | M | Restricted Stock Unit | 233333 | $0.00 | 466,667.0000 | 47,808,817 | 33.33% | 0.49% |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | McFarlane Neil F. | Director | A | Common Stock | 7693 | $0.00 | 49,365.0000 | 41,438,466 | 18.46% | 0.02% |
| Jan. 31, 2024 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 10, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | A | Restricted Stock Unit | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 10, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | McFarlane Neil F. | President and CEO | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | McFarlane Neil F. | Director | A | Common Stock | 9792 | $0.00 | 41,672.0000 | 34,319,291 | 30.72% | 0.03% |